Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterationsKLEIBL, Zdenek; HAVRANEK, Ondrej; NOVOTNY, Jan et al.Breast cancer research and treatment. 2008, Vol 112, Num 1, pp 159-164, issn 0167-6806, 6 p.Article

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypesNAGEL, Jord H. A; PEETERS, Justine K; KLIJN, Jan G. M et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 439-448, issn 0167-6806, 10 p.Article

CHEK2 1100deIC and male breast cancer in the NetherlandsWASIELEWSKI, Marijke; DEN BAKKER, Michael A; VAN DEN OUWELAND, Ans et al.Breast cancer research and treatment. 2009, Vol 116, Num 2, pp 397-400, issn 0167-6806, 4 p.Article

CHEK2*1 100delC Genotyping for Clinical Assessment of Breast Cancer Risk : Meta-Analyses of 26,000 Patient Cases and 27,000 ControlsWEISCHER, Maren; BOJESEN, Stig Egil; ELLERVIK, Christina et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 542-548, issn 0732-183X, 7 p.Article

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in PolandCYBULSKI, Cezary; WOKOLORCZYK, Dominika; NAROD, Steven A et al.Breast cancer research and treatment. 2007, Vol 102, Num 1, pp 119-122, issn 0167-6806, 4 p.Article

Evidence for the receipt of DNA damage stimuli by PML nuclear domainsVARADARAJ, A; DOVEY, C. L; LAREDJ, L et al.Journal of pathology. 2007, Vol 211, Num 4, pp 471-480, issn 0022-3417, 10 p.Article

The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpointsNEUMANN, Jennifer; BOERRIES, Melanie; KÖHLER, Rebecca et al.International journal of cancer (Print). 2014, Vol 134, Num 8, pp 1991-2002, issn 0020-7136, 12 p.Article

Response to DNA damage of CHEK2 missense mutations in familial breast cancerROEB, Wendy; HIGGINS, Jake; KING, Mary-Claire et al.Human molecular genetics (Print). 2012, Vol 21, Num 12, pp 2738-2744, issn 0964-6906, 7 p.Article

Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast CancerCYBULSKI, Cezary; WOKOLORCZYK, Dominika; NAROD, Steven A et al.Journal of clinical oncology. 2011, Vol 29, Num 28, pp 3747-3752, issn 0732-183X, 6 p.Article

Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapyMAUGERI-SACCA, M; BARTUCCI, M; DE MARIA, R et al.Cancer treatment reviews. 2013, Vol 39, Num 5, pp 525-533, issn 0305-7372, 9 p.Article

Orphan receptor TR3 participates in cisplatin-induced apoptosis via Chk2 phosphorylation to repress intestinal tumorigenesisYAO, Lu-Ming; HE, Jian-Ping; CHEN, Hang-Zi et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 2, pp 301-311, issn 0143-3334, 11 p.Article

Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cellsYUTORI, Hirokazu; SEMBA, Shuho; KOMORI, Takahide et al.Cancer science. 2008, Vol 99, Num 3, pp 524-530, issn 1347-9032, 7 p.Article

Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibilityXIANG, He-Ping; GENG, Xiao-Ping; GE, Wei-Wei et al.European journal of cancer (1990). 2011, Vol 47, Num 17, pp 2546-2551, issn 0959-8049, 6 p.Article

Frequency of the CHEK2 1100deIC Mutation among Women with Breast Cancer : An International StudySHIYU ZHANG; PHELAN, Catherine M; LYNCH, Henry et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2154-2157, issn 0008-5472, 4 p.Article

DNA Damage Response in Prostate Cancer Cells after High-intensity Focused Ultrasound (HIFU) TreatmentIDE, Hisamitsu; NAKAGAWA, Takashi; TERADO, Yuichi et al.Anticancer research. 2008, Vol 28, Num 2A, pp 639-643, issn 0250-7005, 5 p.Article

53BP1, an activator of ATM in response to DNA damageMOCHAN, Tamara A; VENERE, Monica; DITULLIO, Richard A et al.DNA repair. 2004, Vol 3, Num 8-9, pp 945-952, issn 1568-7864, 8 p.Article

Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell linesWASIELEWSKI, Marijke; HANIFI-MOGHADDAM, Pejman; HOLLESTELLE, Antoinette et al.Breast cancer research and treatment. 2009, Vol 113, Num 2, pp 285-291, issn 0167-6806, 7 p.Article

Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families : functional analysis in heterozygous individualsJEKIMOVS, C. R; CHEN, X; ARNOLD, J et al.British journal of cancer. 2005, Vol 92, Num 4, pp 784-790, issn 0007-0920, 7 p.Article

IN VIVO RADIOBIOLOGICAL CHARACTERIZATION OF PROTON BEAM AT THE NATIONAL CANCER CENTER IN KOREA: EFFECT OF THE CHK2 MUTATIONSANG SOO KIM; DONG WAN CHOO; KWAN HO CHO et al.International journal of radiation oncology, biology, physics. 2011, Vol 79, Num 2, pp 559-562, issn 0360-3016, 4 p.Article

Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancerZŁOWOCKA, Elzbieta; CYBULSKI, Cezary; SCOTT, Rodney J et al.International journal of cancer. 2008, Vol 122, Num 3, pp 583-586, issn 0020-7136, 4 p.Article

Chk2 molecular interaction map and rationale for Chk2 inhibitorsPOMMIER, Yves; WEINSTEIN, John N; ALADJEM, Mirit I et al.Clinical cancer research. 2006, Vol 12, Num 9, pp 2657-2661, issn 1078-0432, 5 p.Article

The CHEK2* 1100delC mutation has no major contribution in oesophageal carcinogenesisKOPPERT, L. B; SCHUTTE, M; ABBOU, M et al.British journal of cancer. 2004, Vol 90, Num 4, pp 888-891, issn 0007-0920, 4 p.Article

Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohortMCINERNEY, N. M; MILLER, N; ROWAN, A et al.Breast cancer research and treatment. 2010, Vol 121, Num 1, pp 203-210, issn 0167-6806, 8 p.Article

An inherited NBN mutation is associated with poor prognosis prostate cancerCYBULSKI, C; WOKOLORCZYK, D; GOLAB, A et al.British journal of cancer. 2013, Vol 108, Num 2, pp 461-468, issn 0007-0920, 8 p.Article

A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancerSHUYU ZHANG; JUAN LU; FENG WANG et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 7, pp 1251-1258, issn 0143-3334, 8 p.Article